Showing 921-930 of 1784 results for "".
Clinical Evidence on Monotherapy With Menin Inhibitors in R/R AML
https://reachmd.com/programs/cme/clinical-evidence-on-monotherapy-with-menin-inhibitors-in-rr-aml/36180/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Advancing Care: Clinical Innovations on the Horizon
https://reachmd.com/programs/cme/advancing-care-clinical-innovations-on-the-horizon/35881/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Fertility and Safety of IBD Medications During Pregnancy – IBD Pro Webinar Series
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/fertility-and-safety-of-ibd-medications-during-pregnancy-ibd-pro-webinar-series/16104/Join us for this IBD Pro Webinar Series presentation titled “Fertility and Safety of IBD Medications During Pregnancy”. The talk will include a discussion on fertility in IBD patients and the safety profile of IBD treatments during pregnancy. The 40-minute presentation will be followed by a 20-miMenin Inhibitors: Biologic and Clinical Rationale
https://reachmd.com/programs/cme/menin-inhibitors-biologic-and-clinical-rationale/36179/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Expert Recommendations and Key Takeaways
https://reachmd.com/programs/cme/expert-recommendations-and-key-takeaways/36186/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.Recognizing Early Signs of LGMD2I/R9
https://reachmd.com/programs/cme/recognizing-early-signs-of-lgmd2ir9/35878/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.At the Intersection of DB, DED, MGD, and Other Forms of Blepharitis
https://reachmd.com/programs/cme/At-the-Intersection-of-DB-DED-MGD-and-Other-Forms-of-Blepharitis/56704/Join Drs. Devries and Koetting evaluate screening methods for accurate diagnosis of Demodex blepharitis and optimal treatment strategies for this condition.Navigating Treatment Sequencing After Frontline Treatment Failure in CLL
https://reachmd.com/programs/cme/navigating-treatment-sequencing-after-frontline-treatment-failure-in-cll/39260/Dr. Jennifer Brown discusses CLL treatment sequencing after frontline failure, including resistance vs intolerance, MRD-guided strategies, and second-line therapy decisions.Navigating the LGMD2I/R9 Diagnostic Pathway
https://reachmd.com/programs/cme/navigating-the-lgmd2ir9-diagnostic-pathway/35879/Learn about LGMD2I/R9—genetics, diagnosis, treatment, clinical trials, and care gaps—in this expert-led, comprehensive educational video series.Managing Adverse Events Associated With Menin Inhibitors
https://reachmd.com/programs/cme/managing-adverse-events-associated-with-menin-inhibitors/36182/Explore advances in AML that integrate risk stratification, molecular profiling, and menin-targeted therapies to optimize care and improve outcomes.